STAT1 and neoplasm: The SPHK1-S1P signalling axis has also been reported promote the survival of breast CSCs through blocking the tumour suppressor function of signal transducer and activator of transcription 1 (STAT1), with SPHK1 inhibitors sensitising these cells to cell death induced by doxorubicin [78].